Koul Parvaiz A, Mir Hyder, Akram Shabir, Potdar Varsha, Chadha Mandeep S
Department of Internal and Pulmonary Medicine, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.
National Institute of Virology, Pune, Maharashtra, India.
Lung India. 2017 Jan-Feb;34(1):29-33. doi: 10.4103/0970-2113.197099.
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) cause significant morbidity, mortality, and an inexorable decline of lung function. Data from developed countries have shown viruses to be important causes of AECOPD, but data from developing countries like India are scant. We set out to determine the contribution of viruses in the causation of hospitalized patients with AECOPD.
Twin nasopharyngeal/oropharyngeal swabs collected from 233 patients admitted with an acute AECOPD and tested for respiratory viruses including respiratory syncytial virus A and B, parainfluenza were (PIV) 1, 2, 3, and 4, human metapneumovirus (hMPV) A and B, influenza A and B, enterovirus, corona NL65, OC43, and 229E viruses, adenovirus 2 and 4, rhinovirus, and bocavirus, by duplex real time reverse-transcription polymerase chain reaction (qRT-PCR) using CDC approved primers and probes. Samples positive for influenza A were subtyped for A/H1N1pdm09 and A/H3N2 whereas influenza B samples were subtyped into B/Yamagata and B/Victoria subtypes, using primers and probes recommended by CDC, USA.
Respiratory viruses were detected in 46 (19.7%) cases, influenza A/H3N2 and rhinoviruses being the most common viruses detected. More than one virus was isolated in four cases consisting of hMPV-B + adeno-2 + Inf-B; rhino + H3N2, PIV-1 + rhino; and PIV-1+ hMPV-B in one case each. Ancillary supportive therapeutic measures included bronchodilators, antibiotics, steroids, and ventilation (noninvasive in 42 and invasive in 4). Antiviral therapy was instituted in influenza-positive patients. Three patients with A/H3N2 infection died during hospitalization.
We conclude that respiratory viruses are important contributors to AECOPD in India. Our data calls for prompt investigation during an exacerbation for viruses to obviate inappropriate antibiotic use and institute antiviral therapy in viral disease amenable to antiviral therapy. Appropriate preventive strategies like influenza vaccination also need to be employed routinely.
慢性阻塞性肺疾病急性加重(AECOPD)会导致严重的发病、死亡,并使肺功能不可避免地下降。发达国家的数据表明病毒是AECOPD的重要病因,但来自印度等发展中国家的数据却很少。我们旨在确定病毒在住院AECOPD患者病因中的作用。
从233例因急性AECOPD入院的患者中采集双份鼻咽/口咽拭子,使用美国疾病控制与预防中心(CDC)批准的引物和探针,通过双重实时逆转录聚合酶链反应(qRT-PCR)检测呼吸道病毒,包括呼吸道合胞病毒A和B、副流感病毒(PIV)1、2、3和4、人偏肺病毒(hMPV)A和B、甲型和乙型流感病毒、肠道病毒、冠状病毒NL65、OC43和229E病毒、腺病毒2和4、鼻病毒和博卡病毒。甲型流感病毒阳性样本通过使用美国CDC推荐的引物和探针进行A/H1N1pdm09和A/H3N2亚型分型,而乙型流感病毒样本则分为B/山形和B/维多利亚亚型。
46例(19.7%)检测到呼吸道病毒,其中甲型流感病毒H3N2和鼻病毒是最常见的病毒。4例分离出不止一种病毒,分别为hMPV-B + 腺病毒2 + 乙型流感病毒;鼻病毒 + H3N2、PIV-1 + 鼻病毒;以及1例PIV-1 + hMPV-B。辅助支持性治疗措施包括支气管扩张剂、抗生素、类固醇和通气(无创通气42例,有创通气4例)。对流感阳性患者进行了抗病毒治疗。3例A/H3N2感染患者在住院期间死亡。
我们得出结论,呼吸道病毒是印度AECOPD的重要病因。我们的数据表明,在病情加重期间应迅速对病毒进行检测,以避免不适当使用抗生素,并对适合抗病毒治疗的病毒性疾病进行抗病毒治疗。还需要常规采用适当的预防策略,如流感疫苗接种。